Tracy Marshbanks

First Analysis Securities Corp. (FAS) is a research-driven investment organization headquartered in Chicago, Illinois and was founded in 1981. The firm is a subsidiary of First Analysis Corp. FAS serves emerging growth companies with private equity/venture capital investments, corporations with corporate finance and merger and acquisition services, and financial institutions with the public equity research and private equity limited partnerships.

First Analysis Corp (First Analysis) is a venture capital firm founded in 1981 by Francis Oliver Nicklin. The firm is headquartered in Chicago, Illinois.

CSA Medical, Inc. develops endoscopic cryoablation systems. It provides spray cryotherapy medical device solutions that improve patient outcomes, simplify procedures, and reduce the cost of healthcare. The company was founded by Lloyd Shue, Timothy E. Askew and Frank Majerowicz in 1985 and is headquartered in Lexington, MA.

Sonoma Orthopedic Products, Inc. develops and manufactures orthopedic devices. The company was founded by Stephen D. Guntherand and Charles L. Nelson in 2005 and is headquartered in Buffalo Grove, IL.

VIDA Diagnostics, Inc. engages in the production and sale of diagnostic software solutions. The firm?s products help for early detection, evaluation, and treatment of pulmonary diseases including COPD (emphysema, chronic bronchitis), lung cancer, and asthma. The company was founded by Eric Hoffman, Milan Sonka, Joseph Reinhardt, and Geoffrey McLennan in 2004 and is headquartered in Coralville, IA.

Yunu, Inc. provides medical research technology and services to life sciences companies and clinical research environments. The company is based in Pittsboro, NC. The company's aim is to ensure breakthrough therapies are accessible to everyone by unifying medical imaging insights and connecting clinical communities. Yunu is delivering a new standard for clinical trial imaging workflow with thousands of clinical trials relying on the platform daily. The company is serving life science companies and cancer centers to ignite collaboration and accelerate innovation. Yunu offers a resource center for all clinical trial imaging workflow resources in one place and connects cross-site study teams, sponsors, core labs, CROs, and off-site clinical resources through their platform called Yunuverse. The CEO of the company is Jeffrey Sorenson.

ANI Pharmaceuticals, Inc. leader in the specialty pharmaceuticals industry, ANI Pharmaceuticals develops, manufactures and markets top quality prescription and over-the-counter pharmaceuticals, made in the U.S.A. In three facilities with combined manufacturing, packaging and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. The fully-cGMP qualified facilities boast state-of-the-art analytical and stability laboratories for ANI's rapidly expanding research and development program. With several ANDAs pending FDA approval, and in various stages of development, ANI is poised for tremendous growth in the months and years to come!

Cylex is a privately held global life science company that is in the development and manufacture of in vitrodiagnostic products. ImmuKnow is the in vitro diagnostic utilized to detect cell-mediated immunity (CMI) in an immunosuppressed population and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's patented technology provides a platform allowing clinical researchers to simply and reproducibly measure CMI for the development of new diagnostics, biomarkers and companion assays. The company is based in Columbia, MD and was founded in 1992